Although BRG1 mRNA levels were lower in a subset of individual melanoma samples compared to normal skin, the average level of BRG1 was higher in stage III (1.2 fold) and stage IV melanoma (1.7 fold) compared to that in normal skin (Figure. This evidence concerns the gene SMARCA4 and melanoma.